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Background/aim: Enlarged mediastinal lymph nodes can result from serious etiologies including granulomatous disease, neoplasia,
etc., and a rare condition called anthracosis . The aim of this study was to determine the incidence of risk factors and the uptake values
within the anthracotic lymph nodes.
Materials and methods: 106 patients who underwent endobronchial ultrasound transbronchial needle aspiration and were diagnosed
as having anthracosis were analyzed retrospectively. Patients with positive confirmation by surgical biopsies or a 1-year follow-up period
were enrolled.
Results: 201 lymph nodes were sampled from 106 patients. Subcarinal and interlobar lymph nodes were the most commonly affected
stations (36.8% and 34.3%, respectively). The mean durations of exposure to biomass and cigarette smoke were 35.5 and 33 years,
respectively. The mean maximum standardized uptake value (SUVmax) within the lymph nodes was 4.76. The SUVmax of the patients
with associated malignancy was 4.19 and the SUVmax of nonmalignant patients was 5.28. This difference was statistically significant (P
= 0.009).
Conclusion: These findings suggest that anthracosis also affects the mediastinal and hilar stations; it should be considered in differential
diagnosis in patients with mediastinal and hilar lymphadenopathies with intense uptake on positron emission tomography scans,
especially when there is a history of exposure to known risk factors.
Key words: Endobronchial ultrasound, pulmonary anthracosis, positron emission tomography

1. Introduction
Indoor air pollution resulting from the use of solid fuels for
cooking and heating is a significant public health concern in
developing countries, where a substantial proportion of the
population relies exclusively on such fuels for cooking and
heating (1). Like biomass smoke and air pollution, cigarette
smoke also leads to a black pigmentation called anthracosis.
Mediastinal lymphadenopathy is a common clinical problem
and there are several causes, such as infection, neoplasia, and
granulomatous disease. In developing countries, anthracosis
may be another cause of mediastinal lymphadenopathy.
Anthracosis is a benign condition that can also cause
confusion with false-positive positron emission tomography
(PET) images and mimic malignancy (2).
* Correspondence: nilgundemirci@gazi.edu.tr
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F-18 fluorodeoxyglucose (FDG) combined with PET/
computed tomography (CT) imaging detects metabolic
anomalies due to differences in tissue glucose uptake,
and thus metabolic activity. FDG PET/CT is used in the
diagnosis and staging of cancers, monitoring of efficacy
of treatment, and restaging. FDG is not a cancer-specific
agent, and false-positive findings in benign diseases have
been reported (3).
We reviewed patients with mediastinal and hilar
lymphadenopathies that were diagnosed as having nodal
anthracosis with endobronchial ultrasound-guided
transbronchial needle aspiration (EBUS-TBNA). EBUSTBNA is a safe, minimally invasive diagnostic modality
with a high yield for the diagnosis of mediastinal and/
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or hilar adenopathy, as well as for lesions adjacent to
the airways. Because of its high diagnostic yields and
minimally invasive nature, EBUS-TBNA is considered an
alternative method to mediastinoscopy (4).
The finding of high maximum standardized uptake
values (SUVmax) in PET-CT of patients with anthracotic
lymph nodes has attracted attention. This condition is
a common clinical problem in tuberculosis-endemic
countries. We conducted this retrospective evaluation to
determine the incidence of risk factors and the uptake
values within the lymph nodes of anthracotic patients.
2. Materials and methods
All patients who underwent EBUS-TBNA and PET/
CT for staging or diagnosis with mediastinal lymph
node and were diagnosed as nodal anthracosis at the
Atatürk Chest Disease and Chest Surgery Education and
Research Hospital between March 2010 and January
2012 were retrospectively analyzed. Patients with positive
confirmation with surgical biopsies or at least 1-year followup period for mediastinal lymph node were enrolled. All
patients had a PET scan for cancer staging or mediastinal
lymph node etiology. We retrospectively reviewed the
medical records of all patients for basic demographic data,
history of active/passive smoking, occupational history,
drugs used, exposure to biomass fuel composed of animal
dung, and detailed medical history including tuberculosis
and other infections. The duration of the exposure to the
biomass was defined as cumulative years. EBUS-TBNA
was performed under conscious sedation with midazolam,
ketamine, or propofol in an operating room. An EBUS (BFUC180F, Olympus, Tokyo, Japan) was used to examine the
lymph nodes and the ultrasound images were processed
with a dedicated scanner (EU-ME1, Olympus, Tokyo,
Japan). We used 22-gauge needles to sample the lymph
nodes. The cytology specimens were smeared onto slides
and air dried, and stained with Giemsa and other required
stains. We also prepared cell blocks for every patient. For
the cell blocks, the aspirated material was ejected into 10
cc of sterile saline solution and immediately transferred to
the pathology department. After processing through filter
paper, the tissue fragments were fixed in 10% buffered
formalin. Cell blocks were embedded in paraffin, and
sections of 6 µm thickness were obtained and stained
with the requisite stains (hematoxylin–eosin and further
morphological, histochemical, and immunohistochemical
analyses) according to the histopathologist’s decision. The
cell blocks with macroscopic anthracosis and aggregated
anthracotic macrophages on microscopic examination
were enrolled in the study. We also routinely devoted
aspirated material for culture with Löwenstein–Jensen

medium. Rapid on-site evaluation (ROSE) was not
available at our institution. PET/CT was carried out with
an integrated PET/CT scanner (Siemens, Biograph–6True Point). Patients were instructed to fast for at least
6 h before the examination. After confirmation of a
normal peripheral blood glucose level (<180 mg/dL), the
patients received an intravenous injection of 145 µCi/kg
(maximum 200 µCi) of F-18 FDG and rested for 60 min
before the scan. Images were obtained from the base of the
skull to mid-thigh level. The SUV was calculated as the
ratio of tissue radiotracer concentration (mCi/mL) and
injected dose (mCi) at the time of data acquisition divided
by body weight (g). The study was approved by the Ethics
Committee of Atatürk Chest Diseases and Chest Surgery
Education and Research Hospital.
2.1. Statistical analysis
All statistical analyses were carried out using SPSS for
Windows v.17 statistical software. Descriptive statistics
were expressed as mean ± standard deviation for
continuous variables and frequency (in percent) for
categorical variables. Spearman correlation was used to
investigate possible associations between SUVmax and
other variables and between sonographic parameters and
exposure duration. Student’s t-test was used to evaluate
the relationship between categorical variables, SUVmax,
and presence or absence of malignancy within the lymph
nodes. A P value <0.05 was considered statistically
significant.
3. Results
Between March 2010 and January 2012 in total 1138 lymph
nodes were sampled from 546 patients. A total of 201
lymph nodes, cytologically confirmed with anthracosis,
were sampled from 106 patients; 25 of the patients were
female and 81 were male. The mean age was 59.8 ± 11.5
years (Table 1).
There was no comorbid disease in 41 patients, while
65 patients had at least one comorbid disease (chronic
obstructive pulmonary disease, diabetes mellitus, chronic
heart failure, lung cancer, extrapulmonary cancer,
hypertension). While 88 (83%) patients had a history of
exposure to biomass smoke, 83 (78.3%) patients had a
history of active/passive cigarette smoke and 68 (64.2%)
patients had a history of exposure to biomass smoke and
cigarette smoke together; 4 (3.8%) patients had no exposure.
The mean durations of exposure to biomass smoke and
cigarette smoke were 35.45 ± 24.4 and 33.06 ± 28.4 years,
respectively. Eleven patients had a history of tuberculosis
or contact with tuberculosis; however, none of the patients
had active tuberculosis. Moreover, the cultures of aspirated
material obtained with convex probe-EBUS were negative
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Table 1. Study group characteristics.
Age (years)

59.8 (18–80)

Sex (female/male)

25/81

Exposure duration to biomass smoke (years)

35.45 ± 24.4

Exposure to cigarette smoke (package years)

33.06 ± 28.4

Mean SUVmax value

4.76 (1.2–16.8)

for Mycobacterium tuberculosis. Seven of the patients
had bronchoscopic findings of anthracotic pigmentation
on only the overlying mucosa, while two patients had
bronchoscopic findings of anthracotic pigmentation with
bronchial obliteration; other bronchoscopic findings were
normal. While 42 patients had lung cancer (25 squamous,
8 adenocarcinoma, 6 not otherwise specified, 3 small cell
lung cancer, 1 large cell), 5 had extrapulmonary cancer
(1 testicular cancer, 2 stomach cancer, 2 non-Hodgkin
lymphoma). The mean short axis length of the nodes
was 11.79 ± 6.22 mm (13.6 mm in benign cases, 10.2
mm in malignant cases, P < 0.05). The diagnoses were
confirmed surgically for staging in 35 (24.8%) cases and
all of these cases represented lung cancer. The remaining
patients were followed up for at least 1 year and CT scan
showed completely stable appearances. None developed
malignancy.
Subcarinal and interlobar lymph nodes were the
most commonly affected stations (36.8% and 34.3%,
respectively) (Table 2).
The sonographic features of the lymph nodes were
99% hypoechoic, 50.7% heterogeneous, 52.7% oval
shaped, 73.6% distinct margin, 96% necrosis absent,
and 95% calcification absent. No significant interactions
were identified between these sonographic parameters,
SUVmax value and exposure duration. The mean
maximum uptake value within the lymph nodes was 4.76

(1.2–16.8). There was no correlation between SUVmax
values and durations of exposure to biomass and cigarette
smoke (P > 0.05) (Figures 1 and 2). Moreover, the SUVmax
value within the lymph nodes of 4 patients who had no
exposure was 7.18. The SUVmax value of the patients with
associated malignancy was 4.19 and the SUVmax value
of nonmalignant patients was 5.28. This difference was
statistically significant (P = 0.009) (Figures 3 and 4).
4. Discussion
In this retrospective study we evaluated the cases of
mediastinal lymphadenopathy in which lymph node
anthracosis was identified as the final primary diagnosis
using EBUS-TBNA. The nodes were metabolically active
on PET/CT and radiologically indistinguishable from
those in malignancy or granulomatous conditions.
Indoor air pollution, derived from the combustion of
biomass fuel, is the primary source of exposure to biomass
smoke in developing countries. Biomass fuel is any
material derived from plants or animals that is deliberately
burned by humans. Wood is the most common example,
but in areas with little forestation, corn husks, straw, and
animal dung are frequently used alternatives. Many of the
substances in biomass smoke can be detrimental to health.
There is in vitro evidence that many of these substances
are mutagenic, and contain irritants and coagulating
agents that can compromise respiratory system defenses.

Table 2. Sampled lymph nodes according to stations.
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Stations of the lymph nodes

n (percent)

7

74 (36.8%)

11L

37 (18.4%)

11R

32 (15.9%)

4R

28 (13.9%)

4L

26 (12.9%)

Other

4 (1.9%)

Total

201 (100%)
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Figure 1. An endobronchial ultrasound image of anthracotic
lymph node with distinct margin and homogeneous echogenicity
in the right paratracheal area.

Figure 2. An endobronchial ultrasound image of anthracotic
lymph node with indistinct margin and heterogeneous
echogenicity in the subcarinal area.

Figure 3. A 68-year-old man with pulmonary adenocarcinoma presenting for staging evaluation. He had 60
years of exposure to biomass smoke history. Axial positron emission tomography/computed tomography
(PET/CT) (A) shows a right upper lobe 2.5 cm mass, maximum standardized uptake values (SUVmax): 8.23
(blue arrow); right hilar adenopathy SUVmax: 7.04; and subcarinal lymph node SUVmax: 6.04 (red arrow).
(C) Axial PET/CT shows bilateral paratracheal lymph adenopathy, SUVmax: 6.86 (right) and 9.88 (left) (red
arrow). (B and D) CT with mediastinal and lung windows shows a right upper lobe mass. With endobronchial
ultrasound transbronchial needle aspiration, all lymph nodes were found to be anthracotic. The patient underwent mediastinoscopy and lymph nodes were anthracotic. Right upper lobectomy and lymph node dissection
were performed and postoperative pathology of lymph nodes confirmed anthracosis.
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Figure 4. Pathologic preparations of patient in Figure 1. (A) Anthracotic lymph nodes in cell block
(HEX400). (B) Anthracotic pigments, lymphocytes in cytological smears.

Exposure to smoke interferes with the ciliary defenses of
the lungs and decreases several antibacterial properties
of lung macrophages, such as adherence to glass, the
phagocytic rate, and the number of bacteria phagocytosed.
Through these mechanisms the risk of acute and chronic
lung infections and lung cancer increases (5–8). About 50%
of the world population and 90% of rural communities
in developing countries are using biomass as their single
source of cooking fuel (8).
Most women living in rural areas in Turkey use
biomass fuels for domestic energy and are exposed to high
levels of indoor air pollution in their daily lives. Ekici et
al. studied the presence of chronic airway disease (CAD)
in nonsmoking women in Kırıkkale and found that CAD
attributed to biomass smoke exposure was found in 23.1%
of that population (9). In our study, most patients were
living in rural areas and the mean duration of exposure to
biomass smoke was 35.45 ± 24.4 years; only 4 patients had
no history of exposure.
Long-term exposure to biomass smoke, smoking, and
tuberculosis are important causes of anthracosis, which
is black pigment discoloration of the bronchi (10). In
our study, while bronchoscopic findings of anthracotic
pigmentation on only the overlying mucosa were found
in 7 of the patients and anthracotic pigmentation with
bronchial obliteration in 2 patients, other bronchoscopic
findings were normal. Moreover, 11 patients had a history
of tuberculosis or contact with tuberculosis.
EBUS-TBNA is a minimally invasive procedure
performed under local anesthesia and allows real time
assessment and biopsy of mediastinal lymph nodes and,
therefore, often obviates the need for mediastinoscopy.
It has a sensitivity of 95.7%, a specificity of 100%, and
an accuracy of 97.1% in distinguishing benign from
malignant mediastinal and/or hilar lymph nodes (11,12).
While sampling with EBUS the reintroduction of the
stylet into the needle creates friction between the two
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surfaces and causes the release of metal particles. These are
always obviously visible and extracellular and differ from
dusts or anthracosis. Anthracosis is the most frequently
encountered endogenous source of particles in mediastinal
lymph node samples, and is mostly located inside
macrophages, or if “scratched” during spreading of the
smear, has a granular appearance and remains associated
with dust-filled macrophages. Probably, the particles
have been previously inhaled, phagocyted by alveolar
macrophages, and then transported by the lymphatic
system to the nodes, which is in contrast with particles
potentially directly released from the needle. This metal
particle deposition could be associated with a potential
risk of granulomatous inflammatory reaction (13,14).
Anthracosis
often
causes
intrapulmonary
lymphadenopathy, but rarely mediastinal mass, mediastinal
lymphadenopathy, or axillary lymphadenopathy.
Moreover, intrathoracic lymph nodes are often anthracotic
in elderly persons (15). Kirchner et al. analyzed multislice
computed tomography findings of EBUS-TBNA
confirmed anthracosis and found that the most common
site of anthracotic lymph nodes was the subcarinal
area (16). In our study, subcarinal and interlobar lymph
nodes were the most commonly affected stations (36.8%
and 34.3%, respectively). In the same study the authors
concluded that enlarged anthracotic mediastinal lymph
nodes show most often an oval shape and are well-defined,
nodal confluences and calcifications are frequent (16).
Parallel with this, sonographic features may be very useful
for evaluating mediastinal lymph nodes (17). Imai et al.
compared the echoic features of mediastinal lymph nodes
with sarcoidosis to those with lung cancer and found low
and homogeneous echogenicity is a distinct sonographic
feature of lymph nodes with sarcoidosis rather than lung
cancer metastasis (18). Özgül et al. found that, although
lymph nodes of patients with sarcoidosis are often round,
they may have a granular appearance, homogeneous
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echogenicity, and distinct margin, and logistic regression
analysis revealed that the only independent predictive
factor for the diagnosis of sarcoidosis was the presence of a
distinct margin (12). In our study the sonographic features
of the lymph nodes were 99% hypoechoic, 73.6% distinct
margin, 50.7% heterogeneous, 52.7% oval, 96% necrosis
absent, and 95% calcification absent. No significant
interactions were identified between these sonographic
parameters, SUVmax value, and exposure duration.
Further prospective studies are needed that analyze the
echoic findings of anthracotic lymph nodes.
Park et al. evaluated the clinical implication of
microscopic anthracotic pigment in the mediastinal
staging of nonsmall cell lung cancer. Furthermore, they
mentioned that the lymph nodes with microscopic
anthracotic pigment were metabolically active, which
showed high FDG uptake, but usually were histologically
benign. The researchers concluded that the accumulation
of anthracotic particles could impair trapping malignant
cells in lymph nodes (19). In our study, we examined both
benign and malignant cases. Moreover, the SUVmax values
of nonmalignant patients were found to be significantly
higher than in patients with malignant disease.
FDG is a glucose analogue that is transported into
both normal and malignant cells. It is not a cancer-specific
agent, and false-positive findings in benign diseases have
been reported. PET has greater than 90% sensitivity, but
a specificity of only about 80% in diagnosing pulmonary
pathology (20). Inflammatory cells such as neutrophil
and activated macrophages at the site of inflammation
or infection show increased FDG accumulation. Active
granulomatous processes such as tuberculosis and
sarcoidosis, infectious conditions such as pneumocystis
carinii pneumoniae, active fibrotic lesions, pneumoconiosis,
and sclerosing hemangioma have also been reported
to show increased FDG accumulation and cause falsepositive PET scans for malignancy (3,21–22). Imai et al.

compared mediastinal lymph nodes with sarcoidosis to
those with lung cancer. The median value of the SUVmax
of the targeted lymph nodes was 7.7 (range, 4.6–10.1), thus
showing a high uptake indistinguishable from lung cancer
metastatic lymph nodes (18). Moreover, anthracotic
material can cause antigenic stimulation to macrophages.
Anthracotic lymph nodes in the neck, hilar region, and
mediastinum and anthracotic pulmonary nodules have all
been reported to display increased FDG uptake on PET
scanning (23–26). In a brief report of 6 patients with coal
worker’s pneumoconiosis and suspected malignancy, the
mean SUVmax of nodes were 6.0 (2.8–15) (26). In another
case report of mediastinal lymphadenopathy associated
with anthracosis and exposure to wood smoke, the nodes
were metabolically active on PET/CT and the SUVmax
within the lymph nodes was 5–8.4 (14). In this study, the
SUVmax value within the lymph nodes was 4.76 (1–16.8)
and was indistinguishable from malign or granulomatous
conditions.
Our study has some limitations. First, ours is
a retrospective review with a limited number of
patients. Second, we evaluated the cases of mediastinal
lymphadenopathy in which lymph node anthracosis was
identified as the final primary diagnosis and so we could
not compare the echoic findings of anthracosis with
other malignant or benign diseases such as sarcoidosis,
tuberculosis, or malignant lymph nodes.
In conclusion, anthracosis can mimic, or exist with,
benign or malign conditions. Our results suggest that
anthracosis affects not only intrapulmonary lymph nodes,
but also the mediastinal and hilar stations, and should be
considered in the differential diagnosis of patients with
mediastinal and hilar lymphadenopathies with intense
uptake on PET scans in developing countries. Hereby
histopathologic confirmation of mediastinal and hilar
lymphadenopathy is obligatory.

References
1.

Sapkota A, Gajalakshmi V, Jetly DH, Roychowdhury S, Dikshit
RP, Brennan P, Hashibe M, Boffetta P. Indoor air pollution
from solid fuels and risk of hypopharyngeal/laryngeal and
lung cancers: a multicentric case–control study from India.
International Journal of Epidemiology 2008; 37: 321–328.

4.

Nakajima T, Yasufuku K, Takahashi R, Shingyoji M, Hirata
T, Itama M, Matsui Y, Itakura M, Iizasa T, Kimura H.
Comparison of 21-gauge and 22-gauge aspiration needle
during endobronchial ultrasound-guided transbronchial
needle aspiration. Respirology 2011; 16: 90–94.

2.

Onitilo AA, Engel JM, Tanimu SB, Nguyen TC. Anthracosis
and large mediastinal mass in a patient with healed pulmonary
tuberculosis. Clin Med Res 2010; 8: 99–103.

5.

Tuthill RW. Woodstoves, formaldehyde, and respiratory
disease. Am J Epidemiol 1984; 120: 952–955.

3.

Chang JM, Lee JL, Goo MG, Lee HY, Lee JJ, Chung JK, Im JG.
False positive and false negative FDG-PET scans in various
thoracic diseases. Korean J Radiol 2006; 7: 57–69.

6.

Hosgood HD, Boffetta P, Greenland S, Amy Lee YC,
McLaughlin J, Seow A, Duell EJ, Andrew AS, Zaridze
D, Szeszenia-Dabrowska N et al. In-home coal and wood use
and lung cancer risk: a pooled analysis of the International
Lung Cancer Consortium. Environ Health Perspect 2010; 118:
1743–1747.

989

YILMAZ DEMİRCİ et al. / Turk J Med Sci
7.

Akhtar T, Ulah Z, Khan MH, Nazli R. Chronic bronchitis in
women using solid bio mass fuel in rural Peshawar, Pakistan.
Chest 2007; 132: 1472–1475.

8.

Bruce N, Perez-Padilla R, Albalak R. Indoor air pollution in
developing countries: a major environmental and public health
challenge. Bulletin of the World Health Organization 2000; 78:
1078–1092.

9.

Ekici A, Ekici M, Kurtipek E, Akin A, Arslan M, Kara T,
Apaydin Z, Demir S. Obstructive airway diseases in women
exposed to biomass smoke. Environ Res 2005; 99: 93–98.

10.

Bekci TT, Maden E, Emre L. Bronchial anthracofibrosis case
with endobronchial tuberculosis. International Journal of
Medical Sciences 2011; 8: 84–87.

11.

Yasufuku K, Chiyo M, Sekine Y, Chhajed PN, Shibuya K, Lizasa
T, Fujisawa T. Real-time endobronchial ultrasound-guided
transbronchial needle aspiration of mediastinal and hilar
lymph nodes. Chest 2004; 126: 122–128.

12.

Ozgul MA, Cetinkaya E, Kirkil G, Ozgul G, Abul Y, Acat
M, Onaran H, Urer HN, Tutar N, Dincer HE. Lymph node
characteristics of sarcoidosis with endobronchial ultrasound.
Endosc Ultrasound 2014; 3: 232–237.

13.

Gounant V, Ninane V, Janson X, Colombat M, Wislez M,
Grunenwald D, Bernaudin JF, Cadranel J, Fleury-Feith J.
Release of metal particles from needles used for transbronchial
needle aspiration. Chest 2011; 139: 138–143.

14.

Hewitt RJ, Wright C, Adeboyeku D, Ornadel D, Berry M,
Wickremasinghe M, Wright A, Sykes A, Kon OM. Primary
nodal anthracosis identified by EBUS-TBNA as a cause of FDG
PET/CT positive mediastinal lymphadenopathy. Respiratory
Medicine Case Reports 2013; 10: 48–52.

15.

Takemasa A, Bando M, Murayama F, Sohara Y, Hironaka M,
Sugiyama Y. Clinical analysis of intra-pulmonary lymph nodes.
Nihon Kokyuki Gakkai Zasshi 2001; 39: 322–327.

16.

Kirchner J, Mueller P, Broll M et al. Chest CT Findings in
EBUS-TBNA-proven anthracosis in enlarged mediastinal
lymph nodes. Rofo 2014; 186: 1122–1126.

17.

Fujiwara T, Yasufuku K, Nakajima T, Chiyo M, Yoshida
S, Suzuki M, Shibuya K, Hiroshima K, Nakatani Y, Yoshino
I. The utility of sonographic features during endobronchial
ultrasound-guided transbronchial needle aspiration for
lymph node staging in patients with lung cancer: a standard
endobronchial ultrasound image classification system.
Chest 2010; 138: 641–647.

990

18.

Imai N, Imaizumi K, Ando M, Shimokata T, Ogawa T, Ito S,
Hashimoto N, Sato M, Kondo M, Hasegawa Y. Echoic features
of lymph nodes with sarcoidosis determined by endobronchial
ultrasound. Intern Med 2013; 52: 1473–1478.

19.

Park YS, Lee J, Pang JC, Chung DH, Lee SM, Yim JJ, Yang SC,
Yoo CG, Kim YW, Han SK. Clinical implication of microscopic
anthracotic pigment in mediastinal staging of non-small
cell lung cancer by endobronchial ultrasound-guided
transbronchial needle aspiration. J Korean Med Sci 2013; 28:
550–554.

20.

Vansteenkiste JF, Stroobants SG. Positron emission tomography
in the management of non-small cell lung cancer. Hematol
Oncol Clin North Am 2004; 18: 269–288.

21.

Lim JWM, Tang CL, Keng GHW. False positive F-18
fluorodeoxyglucose combined PET/CT scans from suture
granuloma and chronic inflammation: report of two cases and
review of literature. Ann Acad Med Singapore 2005; 34: 457–
460.

22.

Özgül MA, Çetinkaya E, Tutar N, Özgül G, Onaran
H, Bilaceroglu S. Endobronchial ultrasound-guided
transbronchial needle aspiration for the diagnosis of
intrathoracic lymphadenopathy in patients with extrathoracic
malignancy: a study in a tuberculosis-endemic country. Journal
of Cancer Research and Therapeutics 2013; 9: 416–421.

23.

Onitilo AA, Engel JM, Tanimu SB, Nguyen TC. Anthracosis
and large mediastinal mass in a patient with healed pulmonary
tuberculosis. Clin Med Res 2010; 8: 99–103.

24.

Cheng NM, Yeh TW, Ho KC, Ng SH, Hsueh C, Yen TC, Liao
CT. False positive F-18 FDG PET/CT in neck and mediastinum
lymph nodes due to anthracosis in a buccal cancer patient. Clin
Nucl Med 2011; 36: 963–964.

25.

Canbaz F, Kefeli M, Sahin Z, Basoglu T. Anthracotic solitary
pulmonary nodüle imitating lung malignancy on F-18 FDG
PET/CT imaging. Clin Nucl Med 2011; 36: 955–956.

26.

Reichert M, Bensadoun ES. PET imaging in patients with coal
workers pneumoconiosis and suspected malignancy. Journal of
Thoracic Oncology 2009; 4: 649–651.

